The latest international news, analysis and features on the HIV epidemic from AVERT. Share your views and expertise with your peers in the comments box below the articles.
The number of babies born with HIV in Latin America and the Caribbean has decreased by 78 percent – from 10,700 in 2001, to 2,324 in 2013 – according to a new report by the Pan American Health Organization/World Health Organization (PAHO/WHO), and the United Nations Children's Fund (UNICEF). The report entitled, Elimination of Mother-to-Child Transmission of HIV and Congenital Syphilis in the Americas, documents progress made towards the 2015 goals of eliminating mother-to-child transmission (MTCT) of HIV and congenital syphilis in the region.
Retention of care for people taking post-exposure prophylaxis (PEP) for HIV needs to be improved, with only 56 percent of people eligible for PEP completing the 28-day treatment regime. In a study published in AIDS Journal, the authors analyse data on completion rates for PEP, highlighting the need to understand poor adherence rates and integrate this understanding into the broader HIV agenda.
A randomised PrEP trial has closed early due to highly effective results. IPERGAY is the second European PrEP study to be closed early due to high effectiveness. It follows the closure of another randomised study, PROUD, that also was cut short due to highly significant results. This is promising news for changing the future of HIV prevention and treatment, especially for men who have sex with men (MSM).
Protection from HIV infection for women could be as simple as inserting a tampon shaped applicator minutes before having sex. Bio-engineers from the University of Washington have discovered a potential faster way to deliver drugs to protect women from HIV infection. This new method spins the drugs into silk-like fibers that quickly dissolve when in contact with moisture. This could potentially provide a more effective and discreet form of HIV protection, by inserting a drug-loaded applicator into the vagina before having sex.
Prior to the start of the 2014 International AIDS conference in Melbourne, the World Health Organisation (WHO) has published their first consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations.
The 20th International AIDS Conference (AIDS 2014) is being held this year in Melbourne, Australia, from July 20-25th. The biannual conference is one of the most important events in the HIV calendar, and gives an opportunity for a diverse range of voices to come together, share experiences and drive forward positive change for the HIV epidemic. This guest blog series will include reflections from key organisations working in the field of HIV - the HIV/AIDS Alliance, STOPAIDS, CAFOD and Save the Children.
A study conducted in Côte d’Ivoire has revealed that the World Health Organisation (WHO) 2013 antiretroviral (ARV) treatment recommendations regarding serodiscordant couples (when one person is HIV-positive and the other HIV-negative) may only benefit a small number of people. The WHO’s Consolidated ARV Guidelines 2013 state “Partners with HIV in serodiscordant couples should be offered ART to reduce HIV transmission to uninfected partners.” Researchers set out to assess how many people living with HIV (PLHIV) would benefit from this based on their re